高血压及合并急性脑梗死患者血浆同型半胱氨酸与组织型纤溶酶原激活物及其抑制剂的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


The Relationship of Hyperhomocysteinemia in Essencial Hypertension and Acute Myocardiac Infarction Patients with Tissue Plasminogen Activator and Plasminogen activator inhibitor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    为研究高血压及高血压合并急性缺血性脑血管病中高同型半胱氨酸水平对凝血、纤溶系统的影响。用高效液相色谱法分别测定2 1例健康人、2 8例单纯高血压患者及30例高血压合并急性脑梗死患者血浆同型半胱氨酸水平,同时测定纤维蛋白原、组织型纤溶酶原激活物和组织型纤溶酶原激活物抑制剂,分析三组患者上述指标的关系。结果发现,高血压及合并急性脑梗死组同型半胱氨酸、组织型纤溶酶原激活物、组织型纤溶酶原激活物抑制剂及纤维蛋白原均高于健康对照组,高血压合并急性脑梗死组同型半胱氨酸、组织型纤溶酶原激活物抑制剂及纤维蛋白原均高于高血压组,而组织型纤溶酶原激活物低于高血压组。结果提示,高血压及合并急性脑梗死患者存在血浆同型半胱氨酸水平增高,且高同型半胱氨酸浓度可能引起纤溶、凝血功能的紊乱,并在脑梗死的发病中起一定作用。

    Abstract:

    Aim To investigate the effect of hyperhomocysteinemia in hypertension and with acute ischemic cerebrovascular disease (AICVD) about blood coagulation and fibrinolgsis. Methods 28 cases of essencial hypertension patients, 30 cases of essencial hypertension (EH) and AICVD patients and 21 normal subjects were recruited to the study. Plasma total HCY level was measured using high performance liquid chromatography with fluorescence detection, meanwhile fibrinogen (FIB), tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)were measured. Results Plasma HCY, t-PA, PAI and FIB level in AICVD patients and EH patients were higher than that in normal subjects. While PAI level in AICVD patients was higher than that in EH patients. And t-PA level in AICVD patiets was lower than that in EH patients. Conclusions There was hyperhomocystieinmia in EH and AICVD patiets. Hyperhomocysteinemia play an important role in coagulation and fibrinolgsis in patient with EH and AICVD.

    参考文献
    相似文献
    引证文献
引用本文

马庆春,王及华,孙宁玲.高血压及合并急性脑梗死患者血浆同型半胱氨酸与组织型纤溶酶原激活物及其抑制剂的关系[J].中国动脉硬化杂志,2004,12(4):438~439.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2003-10-20
  • 最后修改日期:2004-04-12
  • 录用日期:
  • 在线发布日期: